Introduction:Basic information about CAS 945966-46-1|Apararenone, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | Apararenone |
|---|
| CAS Number | 945966-46-1 | Molecular Weight | 364.391 |
|---|
| Density | 1.4±0.1 g/cm3 | Boiling Point | 594.3±60.0 °C at 760 mmHg |
|---|
| Molecular Formula | C17H17FN2O4S | Melting Point | / |
|---|
| MSDS | / | Flash Point | 313.2±32.9 °C |
|---|
Names
| Name | Apararenone |
|---|
| Synonym | More Synonyms |
|---|
Apararenone BiologicalActivity
| Description | Apararenone (MT-3995) is a novel non-steroidal mineralocorticoid receptor antagonists under development for the treatment of diabetic nephropathies and non-alcoholic steatohepatitis. |
|---|
| Related Catalog | Signaling Pathways >>Metabolic Enzyme/Protease >>Mineralocorticoid ReceptorResearch Areas >>Metabolic DiseaseResearch Areas >>Cardiovascular Disease |
|---|
| Target | Mineralocorticoid receptor[1] |
|---|
| In Vivo | Recently, a phase II clinical trial has been initiated among patients with non-alcoholic steatohepatitis (NASH) in Japan[1]. |
|---|
| References | [1]. Kolkhof P, et al. 30 YEARS OF THE MINERALOCORTICOID RECEPTOR: Mineralocorticoid receptor antagonists: 60 years of research and development. J Endocrinol. 2017 Jul;234(1):T125-T140. |
|---|
Chemical & Physical Properties
| Density | 1.4±0.1 g/cm3 |
|---|
| Boiling Point | 594.3±60.0 °C at 760 mmHg |
|---|
| Molecular Formula | C17H17FN2O4S |
|---|
| Molecular Weight | 364.391 |
|---|
| Flash Point | 313.2±32.9 °C |
|---|
| Exact Mass | 364.089294 |
|---|
| LogP | 1.26 |
|---|
| Vapour Pressure | 0.0±1.7 mmHg at 25°C |
|---|
| Index of Refraction | 1.610 |
|---|
| InChIKey | AZNHWXAFPBYFGH-UHFFFAOYSA-N |
|---|
| SMILES | CC1(C)Oc2cc(NS(C)(=O)=O)ccc2N(c2ccc(F)cc2)C1=O |
|---|
| Storage condition | 2-8℃ |
|---|
Synonyms
| Methanesulfonamide, N-[4-(4-fluorophenyl)-3,4-dihydro-2,2-dimethyl-3-oxo-2H-1,4-benzoxazin-7-yl]- |
| UNII:832663U2NB |
| 832663U2NB |
| N-[4-(4-Fluorophenyl)-2,2-dimethyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-7-yl]methanesulfonamide |
| apararenone |